Swallowing Dysfunction Clinical Trial
Official title:
Promotion of Thickened Feeds to Manage Newborns With Feeding Difficulties
Verified date | March 2012 |
Source | Eastern Virginia Medical School |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Swallowing dysfunction and delay of oral feeding skills in premature infants significantly
delay discharge from the hospital. Thickening oral formula or breast milk feeds with
commercial thickeners and rice cereal has been used in some nurseries with the goal of
promoting development of adequate feeding skills. The objective of this pilot study is to
examine the effect of thickened feeds on premature infants with oral feeding difficulties
due to dysfunction secondary to immature swallowing.
Hypotheses:
- Thickened feeds will lead to a reduction in symptoms secondary to immature swallowing
in 32-40 weeks gestational age infants when compared to non-thickened feeds
- Thickened feeds will promote transition to hospital discharge.
Status | Completed |
Enrollment | 15 |
Est. completion date | September 2010 |
Est. primary completion date | June 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 3 Months |
Eligibility |
Inclusion Criteria: 1. apneas and bradycardias with oral feedings 2. oxygen desaturations with oral feedings 3. excessive coughing or gagging with oral feedings Exclusion Criteria: 1. less than 32 weeks adjusted gestational age 2. greater than 40 weeks adjusted gestational age |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Sentara Norfolk General Hospital | Norfolk | Virginia |
Lead Sponsor | Collaborator |
---|---|
David Oelberg, M.D. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Elimination of symptoms associated with immature swallowing | 2 days | No | |
Secondary | Promotes transition to discharge from hospital | one week | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04597177 -
SW-IMRT Versus ST-IMRT in the Treatment of Head and Neck Cancer
|
N/A |